clinical trial · NCT06388564
A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease
Chronic Graft-versus-host-diseaseAxatilimabRuxolitinibCorticosteroids
brief summary
This study will be conducted to determine the preliminary efficacy of axatilimab in combination with ruxolitinib and to assess the contribution of axatilimab to the combination treatment effect in participants with cGVHD.
started
Oct 11, 2024
primary completion
Jun 1, 2027
completion
Dec 1, 2029
last updated
Mar 23, 2026
official title
A Phase 2, Open-Label, Randomized, Multicenter Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol